Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2019 | Story Ruan Bruwer | Photo Gerda Steyn Twitter
Gerda Steyn
Gerda Steyn, a former student at the University of the Free State, won her first Comrades race on Sunday, setting a new course record.

Winning the Comrades ultra-marathon is the greatest honour of her life and still feels unreal, said Gerda Steyn a day after winning the race in a record time.
 
The former Kovsie student had an incredible race on Sunday, completing the 86,83 km’s in a time of 05:58:54, which is a new record for women in the up run. It is more than 10 minutes faster than the previous record of 06:09:23 set in 2006.
 
It was also the fourth fastest Comrades time ever by a female in the 94-year history of the race.
 
Greatest honour of my life

 
“Being the Comrades winner is the greatest honour of my life. Thank you to an entire nation for carrying me to the line. It feels like a dream,” Steyn said.
 
The 29-year-old Steyn became the first woman in 30 years to win both the Comrades and Two Oceans in the same year. She also won the Two Oceans in 2018 and came second in the Comrades last year.
 
Steyn, who studied Quantity Surveying and Construction Management at the University of the Free State (UFS) between 2009 and 2012, said the record time was discussed beforehand.
 
I went for it
 
“We felt it was possible, but it wasn’t my main goal right from the start of the race. At the halfway mark, I saw it was possible and I went for it.”
 
According to Steyn, the media attention since her win is quite intense. “But I don’t complain. It is such an honour, so I do it with a smile.”
 
At the Two Oceans ultra-marathon in April, she missed out on the 30-year record time by just 53 seconds.
 
Prof Francis Petersen, UFS Rector and Vice-Chancellor, said Steyn was a proud ambassador of the university. “It is always important for me to see how our former students perform. I would like to congratulate her. Well done. She is carrying the Kovsie name with pride,” Prof Petersen said.
 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept